from the (mandated) Systemic Anti-Cancer Therapy (SACT) dataset, and 12 utilised the Blueteq database, owned by Public Health England and NHS England, respectively. The MAAs for HSTs have clearly defined funding and exit strategies, stating that NHS funding would cease for all patients if NICE do not recommend the treatment at the end of the MAA, including those already receiving treatment. In contrast, the 16 MAAs within the CDF lacked stated treatment withdrawal protocols upon negative opinion, focussing more on areas of uncertainty. CONCLUSIONS: MAAs for HST have longer duration with less clearly defined goals than those within the CDF. However, the arrangements for data collection and storage, funding, and exit strategy receive greater emphasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.